John E. Harris

13.8k total citations · 2 hit papers
195 papers, 7.9k citations indexed

About

John E. Harris is a scholar working on Cell Biology, Immunology and Dermatology. According to data from OpenAlex, John E. Harris has authored 195 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Cell Biology, 70 papers in Immunology and 28 papers in Dermatology. Recurrent topics in John E. Harris's work include melanin and skin pigmentation (92 papers), Atherosclerosis and Cardiovascular Diseases (40 papers) and Skin Protection and Aging (18 papers). John E. Harris is often cited by papers focused on melanin and skin pigmentation (92 papers), Atherosclerosis and Cardiovascular Diseases (40 papers) and Skin Protection and Aging (18 papers). John E. Harris collaborates with scholars based in United States, United Kingdom and France. John E. Harris's co-authors include Alan Sunderland, Mehdi Rashighi, Jillian M. Richmond, Michael L. Frisoli, Philip Morris, Amit G. Pandya, Alan Baddeley, Kingsley I. Essien, Iltefat Hamzavi and Khaled Ezzedine and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

John E. Harris

177 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vitiligo: Mechanisms of Pathogenesis and Treatment

2020 330 citations Michael L. Frisoli, Kingsley I. Essien et al. Annual Review of Immunology profile →
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

2022 133 citations David Rosmarin, Thierry Passeron et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John E. Harris United States	48	3.7k	2.6k	1.4k	993	884	195	7.9k
David L. Duffy Australia	58	2.3k 0.6×	1.2k 0.5×	1.8k 1.3×	2.9k 2.9×	922 1.0×	246	11.2k
Grant W. Montgomery Australia	75	1.3k 0.4×	2.6k 1.0×	665 0.5×	7.8k 7.8×	956 1.1×	507	26.1k
Juha Kere Finland	78	1.0k 0.3×	3.1k 1.2×	770 0.6×	10.3k 10.3×	615 0.7×	512	22.1k
Peter Nürnberg Germany	71	2.0k 0.5×	1.5k 0.6×	206 0.2×	9.0k 9.1×	375 0.4×	407	17.7k
Richard P. Gallagher Canada	50	832 0.2×	400 0.2×	2.1k 1.5×	1.1k 1.1×	196 0.2×	167	9.4k
Mark Leppert United States	65	611 0.2×	1.8k 0.7×	379 0.3×	8.0k 8.1×	913 1.0×	164	20.9k
David A. Hinds United States	50	607 0.2×	845 0.3×	392 0.3×	4.2k 4.3×	273 0.3×	95	11.3k
P. Eline Slagboom Netherlands	76	677 0.2×	1.5k 0.6×	558 0.4×	8.8k 8.8×	912 1.0×	465	23.3k
Xavier Estivill Spain	76	1.0k 0.3×	1.0k 0.4×	217 0.2×	10.6k 10.7×	486 0.5×	510	22.2k
Kāri Stefánsson Iceland	80	762 0.2×	1.5k 0.6×	225 0.2×	6.5k 6.6×	229 0.3×	246	17.8k

Countries citing papers authored by John E. Harris

Since Specialization

Citations

This map shows the geographic impact of John E. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Harris more than expected).

Fields of papers citing papers by John E. Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Harris. The network helps show where John E. Harris may publish in the future.

Co-authorship network of co-authors of John E. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Harris. A scholar is included among the top collaborators of John E. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Harris. John E. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosmarin, David, Amit G. Pandya, Thierry Passeron, et al.. (2025). Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo. Dermatology and Therapy. 15(12). 3703–3716.

Okamura, Ken, Aki Nakamura, Yuko Abe, et al.. (2025). A Hairless Mouse Model for Vitiligo: Enhancing Preclinical Therapeutic Evaluation. Journal of Investigative Dermatology. 146(2). 374–382.e4.

Harris, John E., Amit G. Pandya, Mark Lebwohl, et al.. (2024). Safety and Efficacy of Ruxolitinib Cream for the Treatment of Vitiligo: A Randomised Controlled Trial Secondary Analysis at 3 Years. SHILAP Revista de lepidopterología. 4(6). e404–e404. 7 indexed citations

Passeron, Thierry, Khaled Ezzedine, Iltefat Hamzavi, et al.. (2024). Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study. EClinicalMedicine. 73. 102655–102655. 16 indexed citations

Harris, John E., David Rosmarin, Julien Sénéschal, et al.. (2023). 43912 Facial Vitiligo Area Scoring Index Response Maintenance or Shift During 52 Weeks of Ruxolitinib Cream Treatment for Vitiligo: Pooled Analysis of the TRuE-V Phase 3 Studies. Journal of the American Academy of Dermatology. 89(3). AB48–AB48. 1 indexed citations

Howell, Michael, Fiona Kuo, Kang Sun, et al.. (2023). Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream. SHILAP Revista de lepidopterología. 3(6). 100230–100230. 1 indexed citations

Refat, Maggi Ahmed, James P. Strassner, Michael L. Frisoli, et al.. (2023). Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte–Keratinocyte Transplantation Surgery for Vitiligo. Journal of Investigative Dermatology. 143(11). 2275–2282.e6. 6 indexed citations

Refat, Maggi Ahmed, et al.. (2022). Systemic therapies in vitiligo: a review. International Journal of Dermatology. 62(3). 279–289. 11 indexed citations

Riding, Rebecca L., Donna Catalano, Yu‐Jung Lu, et al.. (2022). A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse Vitiligo. Journal of Investigative Dermatology. 142(12). 3294–3303. 10 indexed citations

10.

Fukuda, Keitaro, Ken Okamura, Rebecca L. Riding, et al.. (2021). AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma. The Journal of Experimental Medicine. 218(9). 57 indexed citations

11.

Gellatly, Kyle, James P. Strassner, Kingsley I. Essien, et al.. (2021). scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in T _reg function. Science Translational Medicine. 13(610). eabd8995–eabd8995. 78 indexed citations

12.

Abuabara, Katrina, Jonathan I. Silverberg, Eric L. Simpson, et al.. (2020). International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale. BMJ Open. 10(11). e039928–e039928. 7 indexed citations

13.

Frisoli, Michael L., Kingsley I. Essien, & John E. Harris. (2020). Vitiligo: Mechanisms of Pathogenesis and Treatment. Annual Review of Immunology. 38(1). 621–648. 330 indexed citations breakdown →

14.

Richmond, Jillian M., James P. Strassner, Lucio Zapata, et al.. (2018). Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo. Science Translational Medicine. 10(450). 191 indexed citations

15.

Essien, Kingsley I. & John E. Harris. (2014). Animal models of vitiligo: Matching the model to the question. Dermatologica Sinica. 32(4). 240–247. 22 indexed citations

16.

Whitehouse, R.J.S., et al.. (2014). Fast flow facility for sediment and morphology testing. EPrints - HR Wallingford (HR Wallingford). 3 indexed citations

17.

Chin, Michael S., et al.. (2013). Cavitation Rheology as a Potential Method for In Vivo Assessment of Skin Biomechanics. Plastic & Reconstructive Surgery. 131(2). 303e–305e. 15 indexed citations

18.

Harris, John E.. (2001). One principle and three fallacies of disability studies. Journal of Medical Ethics. 27(6). 383–387. 64 indexed citations

19.

Harris, John E. & Philip Morris. (1984). Everyday memory : actions and absent-mindedness. Academic Press eBooks. 386 indexed citations

20.

Jenkin, Penelope M. & John E. Harris. (1962). Kinetic and metabolic hormones. Pergamon Press eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact